Cor pulmonale - The Medical Post | Trusting Medicine
... Cor pulmonale is defined as an alteration in the structure and function of the right ventricle caused by a primary disorder of the respiratory system – lung parenchyma, lung vasculature or thoracic ...
... Cor pulmonale is defined as an alteration in the structure and function of the right ventricle caused by a primary disorder of the respiratory system – lung parenchyma, lung vasculature or thoracic ...
Diagnosis and Management of Life Threatening Cardiac Emergencies
... IV Diltiazem: 0.05 - 0.15 mg/kg IV over 5 - 10 minutes up to max dose of 0.3 mg/kg; then CRI (0.12 - 0.24 mg/kg/h) PO Diltiazem: 0.5 - 2 mg/kg PO q 8 h PO Dilitazem extended release (dilacor ER): 2 - 3 mg/kg PO q 12 h ...
... IV Diltiazem: 0.05 - 0.15 mg/kg IV over 5 - 10 minutes up to max dose of 0.3 mg/kg; then CRI (0.12 - 0.24 mg/kg/h) PO Diltiazem: 0.5 - 2 mg/kg PO q 8 h PO Dilitazem extended release (dilacor ER): 2 - 3 mg/kg PO q 12 h ...
Recognition And Treatment Of Fetal And Neonatal Arrhythmias
... progression to complete block Consider IVIG Both have ha e side effects Not effective in those with structural heart disease ...
... progression to complete block Consider IVIG Both have ha e side effects Not effective in those with structural heart disease ...
OMB No. 0925-0046, Biographical Sketch Format Page
... My PhD research focused on the role of inherited cardiomyopathies due to mutations in the LMNA gene. Patients that carry Lamin A/C mutations giving rise to either pure dilated cardiomyopathy, or EmeryDreifuss muscular dystrophy, or limb-girdle muscular dystrophy appeared to have an increased risk of ...
... My PhD research focused on the role of inherited cardiomyopathies due to mutations in the LMNA gene. Patients that carry Lamin A/C mutations giving rise to either pure dilated cardiomyopathy, or EmeryDreifuss muscular dystrophy, or limb-girdle muscular dystrophy appeared to have an increased risk of ...
Short-term heart rate variability during a cognitive challenge in
... age-related difference in resting heart period. Heart period changes very little with age in the absence of disease (see [21] for a review). These data indicate a main effect of the simple reaction time task on HRV (SDNN and spectral measures) and systolic blood pressure. These findings suggest a wi ...
... age-related difference in resting heart period. Heart period changes very little with age in the absence of disease (see [21] for a review). These data indicate a main effect of the simple reaction time task on HRV (SDNN and spectral measures) and systolic blood pressure. These findings suggest a wi ...
Management of arrhythmias in heart failure. What a practicing
... /atrial flutter. Sometimes ICD can misread other rhythms as VT/VF especially when the rate of the on-going arrhythmia is greater than the pre-set detection rate of the ICD. In this scenario, the ICD can deliver a shock, which is labelled as inappropriate. Inappropriate ICD shocks were associated wit ...
... /atrial flutter. Sometimes ICD can misread other rhythms as VT/VF especially when the rate of the on-going arrhythmia is greater than the pre-set detection rate of the ICD. In this scenario, the ICD can deliver a shock, which is labelled as inappropriate. Inappropriate ICD shocks were associated wit ...
BME lecture 9 - cardiovascular modeling (Sept 23, 2004)
... Determining PELAST and RS during Ejection: Any shortening of the cardiac muscle (i.e. ejection) results in less generated LVP, as energy that could have been used to develop LVP is lost in the myocardial friction or resistance, RS, (PELAST - PDASHPOT = LVP). Since there is no aortic flow during the ...
... Determining PELAST and RS during Ejection: Any shortening of the cardiac muscle (i.e. ejection) results in less generated LVP, as energy that could have been used to develop LVP is lost in the myocardial friction or resistance, RS, (PELAST - PDASHPOT = LVP). Since there is no aortic flow during the ...
Phys chapter 11
... o 1.0-1.5 mV if electrodes are placed on separate arms or an arm and a leg Time between beginning of P wave and beginning of QRS complex is the P-Q interval – interval between beginning of electrical excitation of atria and beginning of excitation of ventricles – normally about 0.16 sec – can also b ...
... o 1.0-1.5 mV if electrodes are placed on separate arms or an arm and a leg Time between beginning of P wave and beginning of QRS complex is the P-Q interval – interval between beginning of electrical excitation of atria and beginning of excitation of ventricles – normally about 0.16 sec – can also b ...
Cardiac Monitoring Skills
... Background of Electrical Flow of the Heart Electricity stimulates the heart muscle to contract. It spreads through the heart sequentially changing the polarity of the cell’s interior from negative to positive (depolarization). This causes contraction of the muscle. The internal cell positive polari ...
... Background of Electrical Flow of the Heart Electricity stimulates the heart muscle to contract. It spreads through the heart sequentially changing the polarity of the cell’s interior from negative to positive (depolarization). This causes contraction of the muscle. The internal cell positive polari ...
(Microsoft PowerPoint - Poporodn\355 adaptace_MP_A_def)
... types – 24th week = surfactant (secretion can be increased by betamethasone) ...
... types – 24th week = surfactant (secretion can be increased by betamethasone) ...
The Human Heart:
... The Most Important Muscle in the Human Body (1) As you have already learned, there are muscles all over your body. All of them are important, but not all of them are vital. The muscle you cannot do without is inside your chest. It is the heart! (2) The heart is responsible for two things. First, thr ...
... The Most Important Muscle in the Human Body (1) As you have already learned, there are muscles all over your body. All of them are important, but not all of them are vital. The muscle you cannot do without is inside your chest. It is the heart! (2) The heart is responsible for two things. First, thr ...
Snímek 1 - med.muni
... refers to the alteration in size, shape and thickness of both the infarcted myocardium (which thins and expands) and the compensatory hypertrophy that occurs in other areas of the myocardium. The resultant global ventricular dilatation may help maintain the stroke volume of the heart. ...
... refers to the alteration in size, shape and thickness of both the infarcted myocardium (which thins and expands) and the compensatory hypertrophy that occurs in other areas of the myocardium. The resultant global ventricular dilatation may help maintain the stroke volume of the heart. ...
05 Heart Rate Response LQ
... Most people have experienced the sensation of dizziness after standing abruptly from a seated or squatting position. This effect can be seen in healthy individuals, but it is accentuated in the elderly and in certain conditions including dehydration and Parkinson’s disease. In these cases, the incre ...
... Most people have experienced the sensation of dizziness after standing abruptly from a seated or squatting position. This effect can be seen in healthy individuals, but it is accentuated in the elderly and in certain conditions including dehydration and Parkinson’s disease. In these cases, the incre ...
没有幻灯片标题
... 1. Sackner2Bernstein JD, Skop icki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely de-compensated heart failure. Circulation, 2005, 111 (12) : 1487-1491. 2. Sackner2Bernstein JD, KowalskiM, FoxM, et al. Short-term risk of death after treatment with nesiriti ...
... 1. Sackner2Bernstein JD, Skop icki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely de-compensated heart failure. Circulation, 2005, 111 (12) : 1487-1491. 2. Sackner2Bernstein JD, KowalskiM, FoxM, et al. Short-term risk of death after treatment with nesiriti ...
A Cineradiographic Study of the Snake Heart
... could be seen. It originated slightly to the left of the atrio-ventricular valves and could be followed to a point at the left posterolateral aspect of the ventricle. This last point was marked by a small indentation, which was most clearly observed before the isometric contraction started (fig. 2, ...
... could be seen. It originated slightly to the left of the atrio-ventricular valves and could be followed to a point at the left posterolateral aspect of the ventricle. This last point was marked by a small indentation, which was most clearly observed before the isometric contraction started (fig. 2, ...
CAR
... [email protected] INTRODUCTION: - Cor triatriatum, first described in 1868 by Church1, is an uncommon congenital cardiac anomaly which is found in only 0.1% of patients with congenital heart disease 2. Cor triatriatum results from embryologic failure of the common pulmonary vein to become inco ...
... [email protected] INTRODUCTION: - Cor triatriatum, first described in 1868 by Church1, is an uncommon congenital cardiac anomaly which is found in only 0.1% of patients with congenital heart disease 2. Cor triatriatum results from embryologic failure of the common pulmonary vein to become inco ...
4- Cardiac output, exercise and cardiac hypertrophy
... Arterial O2 can be measured from sample taken from any artery in the systemic circulation as it has same O2 concentration, while venous O2 concentration is measured from pulmonary artery (by catheterization) because venous O2 concentration differ at different vein of systemic circulation. 2- Indicat ...
... Arterial O2 can be measured from sample taken from any artery in the systemic circulation as it has same O2 concentration, while venous O2 concentration is measured from pulmonary artery (by catheterization) because venous O2 concentration differ at different vein of systemic circulation. 2- Indicat ...
- Wiley Online Library
... the clinical significance of plasma neopterin, an inflammatory biomarker, in HFpEF patients. Methods and results In the present study, we recruited consecutive HFpEF patients hospitalized in Kumamoto University Hospital, and further measured plasma neopterin by high-performance liquid chromatography a ...
... the clinical significance of plasma neopterin, an inflammatory biomarker, in HFpEF patients. Methods and results In the present study, we recruited consecutive HFpEF patients hospitalized in Kumamoto University Hospital, and further measured plasma neopterin by high-performance liquid chromatography a ...
depolarization waves.
... based on the ability of excitable tissue, such as heart muscle (myocardium), to change its membrane permeability to sodium (Na+) and potassium ions (K+). ...
... based on the ability of excitable tissue, such as heart muscle (myocardium), to change its membrane permeability to sodium (Na+) and potassium ions (K+). ...
Cardiovascular_System - walker2015
... Cardiac output (CO) – Amount of blood pumped by each ventricle of the heart in one minute Stroke volume (SV) – Volume of blood pumped by each ventricle in one contraction (each heartbeat) ...
... Cardiac output (CO) – Amount of blood pumped by each ventricle of the heart in one minute Stroke volume (SV) – Volume of blood pumped by each ventricle in one contraction (each heartbeat) ...
Cardiac Cycle Phase Identification in Echocardiography Images
... basic part to be functioned well else there will be some existence of some dysfunction in the heart. There are also the two states of the heart in the cardiac cycle: 1) Diastole 2) Systole. The cardiac cycle for an normal person will take place for about 60-100/min. The Diastolic function is the pro ...
... basic part to be functioned well else there will be some existence of some dysfunction in the heart. There are also the two states of the heart in the cardiac cycle: 1) Diastole 2) Systole. The cardiac cycle for an normal person will take place for about 60-100/min. The Diastolic function is the pro ...
PDF - Bentham Open
... pathophysiology of the two syndromes. A number of new drugs have shown promise but they will not be commercially available for several years. For the time being, aggressive treatment of non-cardiac comorbidities is the only option available for the management of HFpEF. Treatment of anaemia, sleep di ...
... pathophysiology of the two syndromes. A number of new drugs have shown promise but they will not be commercially available for several years. For the time being, aggressive treatment of non-cardiac comorbidities is the only option available for the management of HFpEF. Treatment of anaemia, sleep di ...
Perforation of the Heart during Cardiac Catheterization
... justify the risk of its use. In this case, there is reason to suspect that perforation probably did not occur with the Cournand catheter, which is relatively flexible and which was not inserted in the area of the apex of the right ventricle. The perforation occurred more likely during the insertion ...
... justify the risk of its use. In this case, there is reason to suspect that perforation probably did not occur with the Cournand catheter, which is relatively flexible and which was not inserted in the area of the apex of the right ventricle. The perforation occurred more likely during the insertion ...
Heart failure
Heart failure (HF), often referred to as congestive heart failure (CHF), occurs when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. The terms chronic heart failure (CHF) or congestive cardiac failure (CCF) are often used interchangeably with congestive heart failure. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling. The shortness of breath is usually worse with exercise, while lying down, and may wake the person at night. A limited ability to exercise is also a common feature.Common causes of heart failure include coronary artery disease including a previous myocardial infarction (heart attack), high blood pressure, atrial fibrillation, valvular heart disease, excess alcohol use, infection, and cardiomyopathy of an unknown cause. These cause heart failure by changing either the structure or the functioning of the heart. There are two main types of heart failure: heart failure due to left ventricular dysfunction and heart failure with normal ejection fraction depending on if the ability of the left ventricle to contract is affected, or the heart's ability to relax. The severity of disease is usually graded by the degree of problems with exercise. Heart failure is not the same as myocardial infarction (in which part of the heart muscle dies) or cardiac arrest (in which blood flow stops altogether). Other diseases that may have symptoms similar to heart failure include obesity, kidney failure, liver problems, anemia and thyroid disease.The condition is diagnosed based on the history of the symptoms and a physical examination with confirmation by echocardiography. Blood tests, electrocardiography, and chest radiography may be useful to determine the underlying cause. Treatment depends on the severity and cause of the disease. In people with chronic stable mild heart failure, treatment commonly consists of lifestyle modifications such as stopping smoking, physical exercise, and dietary changes, as well as medications. In those with heart failure due to left ventricular dysfunction, angiotensin converting enzyme inhibitors or angiotensin receptor blockers along with beta blockers are recommended. For those with severe disease, aldosterone antagonists, or hydralazine plus a nitrate may be used. Diuretics are useful for preventing fluid retention. Sometimes, depending on the cause, an implanted device such as a pacemaker or an implantable cardiac defibrillator may be recommended. In some moderate or severe cases cardiac resynchronization therapy (CRT) may be suggested or cardiac contractility modulation may be of benefit. A ventricular assist device or occasionally a heart transplant may be recommended in those with severe disease despite all other measures.Heart failure is a common, costly, and potentially fatal condition. In developed countries, around 2% of adults have heart failure and in those over the age of 65, this increases to 6–10%. In the year after diagnosis the risk of death is about 35% after which it decreases to below 10% each year. This is similar to the risks with a number of types of cancer. In the United Kingdom the disease is the reason for 5% of emergency hospital admissions. Heart failure has been known since ancient times with the Ebers papyrus commenting on it around 1550 BCE.